Cargando…
Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with no known effective therapy. It is often assumed, but has not been objectively evaluated, that pulmonary inflammation subsides as IPF progresses. The goal of this work was to assess changes in the degree of inflammatory cell...
Autores principales: | Todd, Nevins W, Scheraga, Rachel G, Galvin, Jeffrey R, Iacono, Aldo T, Britt, E James, Luzina, Irina G, Burke, Allen P, Atamas, Sergei P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617818/ https://www.ncbi.nlm.nih.gov/pubmed/23576879 http://dx.doi.org/10.2147/JIR.S40673 |
Ejemplares similares
-
Molecular and cellular mechanisms of pulmonary fibrosis
por: Todd, Nevins W, et al.
Publicado: (2012) -
Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History
por: Kalchiem-Dekel, Or, et al.
Publicado: (2018) -
CCR6 is not necessary for functional effects of human CCL18 in a mouse model
por: Luzina, Irina G, et al.
Publicado: (2012) -
Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond
por: Lillehoj, Erik P., et al.
Publicado: (2022) -
Survival in pulmonary fibrosis combined with emphysema: likely defined by characteristics of specific patient subpopulations
por: Todd, Nevins W, et al.
Publicado: (2011)